Could a common diabetes drug ease Parkinson's symptoms?

NCT ID NCT05781711

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2 trial tested whether metformin, a widely used diabetes medication, could improve symptoms in people with Parkinson's disease. Sixty participants who were already taking levodopa received either metformin or a placebo. Researchers measured changes in movement and daily function using a standard rating scale, and also looked at blood markers like brain-derived neurotrophic factor.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
metformin
What this could lead to
If it works, metformin could become an add-on treatment to help control Parkinson's symptoms better.
What could go wrong
This is a small, early-phase trial with only 60 participants. Metformin is not a cure and may not show significant benefit over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of Medicine, Menoufia University

    Tanta, Shebeen El-Kom, 32511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.